Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease (Q33387233)

26 July 2017

title

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease (English)

1 reference

26 July 2017

0 references

1 reference

Josef M Penninger

0 references

Heather N Reich

1 reference

26 July 2017

Andrew M Herzenberg

1 reference

26 July 2017

Gavin Y Oudit

1 reference

26 July 2017

James W Scholey

series ordinal

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

26 July 2017

1 reference

26 July 2017

1 reference

26 July 2017

1 reference

26 July 2017

page(s)

1610-1616

1 reference

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

ACE2, a new regulator of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Renal ACE2 expression in human kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Angiotensin-converting enzyme 2 is an essential regulator of heart function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

ACE and ACE2 activity in diabetic mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Gender disparity in living renal transplant donation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.497

7 January 2021

Identifiers

DOI

10.1038/KI.2008.497

1 reference

Dimensions Publication ID

26 July 2017

1037663121

0 references

1 reference